Normal Echocardiographic Parameters of Indian Population and Comparison With the ASE Reference Range
TTE IN INDIAN
1 other identifier
interventional
150
1 country
2
Brief Summary
Echocardiography forms one of the most used modality in the evaluation of cardiac anatomy and functions in both patients with cardiac symptoms and in healthy individuals for occupational and research purpose. The interpretation of any medical investigation including echocardiographic report is based on its comparison with the normal range for that parameter, which is known to vary depending on the age, sex, body surface area (BSA), ethnicity and race. Since most of the medical/surgical treatment decisions are made based on the echocardiographic reports, the interpretation of results should be accurate. Even though there are many studies defining reference ranges of echocardiographic parameters, most of them were based on studies conducted in Western and European population, who shows considerable difference in their anthropometric measurements from the Indian population. Hence for the accurate diagnosis of any cardiac abnormalities, the reference values should have been derived from studies conducted in population of that particular race and ethnicity who are free of risk factors for the cardiac disease. Hence the investigator planned to conduct a study to determine the normal Echocardiographic parameters and compare it with the reference range of established by American society of echocardiography (ASE).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Jan 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2017
CompletedFirst Posted
Study publicly available on registry
October 12, 2017
CompletedStudy Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedJanuary 17, 2018
January 1, 2018
6 months
September 27, 2017
January 12, 2018
Conditions
Outcome Measures
Primary Outcomes (14)
EDLVID
End diastole left ventricle internal diameter
up to 30 minutes
ESLVID
End systole left ventricle internal diameter
up to 30 minutes
EDIVST
End diastole inter-ventricular septum thickness
up to 30 minutes
ESIVST
End systole inter-ventricular septum thickness
up to 30 minutes
EDPWT
End diastole posterior wall thickness
up to 30 minutes
ESPWT
End systole posterior wall thickness
up to 30 minutes
LVEF
Left ventricle ejection fraction
up to 30 minutes
LV strain
Left ventricle strain
up to 30 minutes
TAPSE
Tricuspid annular plane systolic excursion
up to 30 minutes
RV FAC
Right ventricle fractional area change
up to 30 minutes
RV TEI index
Right ventricle TEI index
up to 30 minutes
Mitral and tricuspid E',A', S'
Mitral and tricuspid annular tissue velocities
up to 30 minutes
RVOT diameter
Right ventricle outflow tract diameter
up to 30 minutes
Mitral tricuspid aortic pulmonary annulus diameter
Mitral tricuspid aortic pulmonary annulus diameter
up to 30 minutes
Study Arms (1)
TRANSTHORACIC ECHOCARDIOGRAM
EXPERIMENTALIndividuals who visit pre-anaesthetic check up (PAC) clinic for minor surgery which includes plastic, rhino-otolaryngeal, ophthalmologic, orthopaedic, abdominal, urological, gynaecological surgeries, who are free of cardiac disease or any known risk factors for the cardiac disease like chronic alcoholism, chronic smoking, metabolic syndrome, morbid obesity
Interventions
TRANSTHORACIC ECHOCARDIOGRAM WILL BE DONE IN THE PARTICIPANTS WHICH IS NON-INVASIVE
Eligibility Criteria
You may qualify if:
- \- Age between18 to 60 years
You may not qualify if:
- History of congenital or acquired cardiac abnormality
- Symptoms and Signs suggestive of any cardio-respiratory disease
- Systemic hypertension SBP more than 140 and DBP more than90
- Known case of Diabetes mellitus or signs and symptoms suggesting like polyuria, polydipsia, autonomic dysfunction
- History of long term exercise
- Systemic disease like chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease
- LVH or any abnormality in ECG
- Abnormal chest X-ray
- Obesity defined by BMI MORE THAN 25 kg/m2)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
PGIMER
Chandigarh, 160012, India
PGIMER
Chandigarh, 160012, India
Study Officials
- PRINCIPAL INVESTIGATOR
GANESH KUMAR, MD
PGIMER, CHANDIGARH, INDIA
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 27, 2017
First Posted
October 12, 2017
Study Start
January 1, 2018
Primary Completion
June 30, 2018
Study Completion
June 30, 2018
Last Updated
January 17, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share